Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study46
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis35
Effects of p-cresol, a uremic toxin, on cancer cells34
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients28
Molecular basis of heterogeneity in small cell lung cancer28
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report24
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review23
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis21
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study20
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity20
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma20
Compression of superior vena cava and azygos vein by a giant mediastinal mature cystic teratoma: a case report20
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma18
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment17
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial17
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer17
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer17
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors17
0.081027984619141